ProfessorBrad Sutherland

Professor

Medicine

  • Professor
    Medicine
  • +61 3 6226 7634 (Work)
  • Tasmanian School of Medicine, Medicine, MS2, Level 4, 437a Medical Sciences Precinct, Hobart CBD Campuses, TAS

FUNDED PROJECTS

  • GRANT
    Acquisition of a high-frequency ultrasound platform to supercharge discovery research in Tasmania
    1 Jan 2027 - 31 Dec 2029
    People funded by this grant:
    • Premilovac D,
    • Sutherland B,
    • Young K,
    • Flies A,
    • Guven N
    Project Total: $141,000; This equipment grant application to the Ian Potter Foundation will lead to acquisition of a new, purpose built and state of the art ultrasound machine for preclinical work. Currently available machines at UTAS are clinical machines and are not able to adequately support preclinical imaging due to temporal and spatial resolution limits. This new machine will enable live in vivo imaging of any organ in the rat/mouse/zebra fish, measurement of cardiovascular function, targeted drug delivery using microbubbles (contrast agents) and an ultrasound guided micro-injection platform for delivery of compounds or genetic material without off target effects. Funded by: Ian Potter Foundation - Grant - Medical Research ($141,000); University of Tasmania ($141,000).
  • GRANT
    The brain has a bin; how is it emptied?
    1 Jan 2026 - 31 Dec 2028
    People funded by this grant:
    • Coulson E,
    • Sutherland B,
    • Chuang K-H
    Project Total: $1,240,586; Is it not yet clear how metabolic waste is cleared from the brain. We propose that it occurs most actively during wakefulness rather than sleep, challenging traditional views. The project will determine rates of waste efflux in he brains of mice in wakefulness and sleep, determine the role of arteries and veins in the clearance system, and explore the cellular mechanisms by which metabolites are cleared through water channels. The study aims to address knowledge gaps in the current glymphatic model using innovative techniques to understand brain metabolism homeostasis and optimal function. Findings could also offer insights into maintaining cognitive health and in the future, mitigating age-related neurodegenerative diseases. Funded by: Australian Research Council - Discovery Project - EOI; University of Melbourne; University of Tasmania.
  • GRANT
    Vascular Vulnerabilities and MS Pathology
    Multiple Sclerosis Australia1 Jan 2026 - 31 Dec 2028
    People funded by this grant:
    • Young K,
    • Sutherland B,
    • Moloney R,
    • Fortune A
    Project Total: $397,239; The brain has extremely high oxygen and energy demands. This makes blood supply critical for neuron health. As people with Multiple Sclerosis (MS) have a reduced brain blood flow, this could directly promote neurodegeneration and disability progression. However, it is unclear whether genetic factors, signals within the lesion environment, or a combination of both, lead to brain hypoperfusion in people with MS. To examine this, we will use induced pluripotent stem cells (iPSCs), generated from the blood of people with and without MS, to generate the vascular cell types that regulate brain blood flow. iPSCs and the resulting vascular cell types will have the same DNA sequence as the person they were made from. We will expose these cells to control conditions, as well as the signals they would experience inside an MS lesion to determine how the properties that regulate capillary barrier integrity and blood flow are impacted. We will also determine how changing blood flow can impact the level of myelin loss and neuronal injury in an inflammatory model of demyelination. Our project has the potential to identify ways to target blood vessels to improve integrity and blood flow regulation within the brain of a people with MS. We predict that even after MS develops, targeting and improving blood vessel health could be critical for supporting brain remyelination and preventing neuron cell death. As neuron cell death causes disability to increase, our goal is to save neurons and reduce disease progression. Funded by: Multiple Sclerosis Australia - Project ($397,626); University of Tasmania.
  • GRANT
    Learning how to use human brain banks to uncover new mechanisms linked to dementia
    1 Mar 2025 - 1 Mar 2026
    People funded by this grant:
    • Morris G,
    • Sutherland B,
    • King A,
    • De Luca G
    Project Total: $15,000; In this project I will travel to Oxford University in the United Kingdom to access tissue from a brain bank. This brain bank, known as OPTIMA, contains brain tissue from people that were either cognitively impaired or cognitively normal during life. Alongside brain tissue, many other pieces of information were collected about each participant including detailed medical histories, neuropsychological assessments, brain scans during life, blood, urine and cerebrospinal fluid and DNA. This brain bank therefore offers the opportunity to study changes in the brains of patients that lived with dementia, comparing them to healthy individuals. My research group has recently received funding from the Australian National Health and Medical Research Council (NHMRC) to access tissue from the bank and to purchase the equipment necessary to undertake a detailed histopathological study of changes in these brains. We are particularly interested in looking at changes in the blood vessels of the brain in several different subgroups of patients that had dementia. I am applying for funding to fly to and stay in Oxford for a 4-month period in order to conduct the research necessary to achieve these aims. In Australia we are establishing brain banks across the country, so learning how to use and gain information from a brain bank will enable me to bring these skills back to Australia as we work toward utilising the banks we are establishing. During my travels, I also plan to attend a conference to present my research to the international community, and to meet with researchers in the UK affiliated with the newly formed UK Dementia Research Institute. These meetings will enable me to make connections with leading researchers in the UK that I will leverage to improve the science I am undertaking in Australia. Funded by: Dementia Australia Research Foundation Ltd - Grant-Travel ($15,000); University of Tasmania.
  • GRANT
    Acquiring a 5-colour confocal microscope for research to improve health outcomes in Tasmania
    1 Nov 2024 - 31 Oct 2025
    People funded by this grant:
    • Young K,
    • Fletcher J,
    • King A,
    • Sutherland B,
    • Blizzard C
    Project Total: $150,000; We aim to purchase a spinning disc confocal microscope to be housed in the medical sciences precinct at the University of Tasmania. The microscope will be used for current and future medical research projects, and will be available for use by other STEM researchers, increasing our imaging capacity and capability. Funded by: Ian Potter Foundation - Grant ($150,000); University of Tasmania ($226,997).
  • GRANT
    Centre of multiple sclerosis research translation
    1 Jul 2024 - 30 Jun 2029
    People funded by this grant:
    • Young K,
    • Taylor B,
    • Reay W,
    • van der Mei I,
    • Zhou Y
    Project Total: $3,000,000; Multiple Sclerosis (MS) is a disease that causes inflammation in the brain. People with MS need treatments that will protect and repair the brain. In our MS Centre, people with MS, researchers, and doctors work together to find out how MS affects the brain. This gives us clues about the type/s of drugs that might help. We grow brain cells in the lab, add the potential drugs, and measure the effect. Drugs that protect brain cells are then tested in the clinic to see how they help people with MS. Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Grant-Centre of Research Excellence ($6,000,000); University of Tasmania ($177,384).
  • GRANT
    Checking the pulse of pericytes: Do microglia cause a breakdown of brain blood vessels in Alzheimer's disease?
    1 Jul 2024 - 30 Jun 2028
    People funded by this grant:
    • Sutherland B,
    • Morris G,
    • De Luca G,
    • Ziebell J
    Project Total: $1,278,438; Pericytes are cells that control blood flow through capillaries. Microglia in the brain respond to inflammation. Some microglia interact with pericytes which may control blood flow and brain function. In Alzheimers disease (AD), this interaction is disrupted. This proposal will use innovative techniques to understand how pericytes and microglia interact and how this goes wrong in AD. This opens up new potential treatment options for AD. Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Grant-Ideas ($2,556,876); University of Tasmania ($116,214).
  • GRANT
    Investigating the 'no reflow' phenomenon in a clinically relevant model of stroke
    1 Jan 2024 - 31 Dec 2024
    People funded by this grant:
    • Hood R,
    • Morris G,
    • Beard D,
    • Sutherland B,
    • Farr T
    Project Total: $50,000; Ischaemic stroke is a leading cause of death and disability worldwide. The most common cause of stroke (~85%) is blockage of a brain blood vessel by a clot. The current goal of stroke treatment is to remove the clot from the vessel (recanalization) and restore blood flow to the affected area (reperfusion) as fast as possible. However, despite successful recanalization, many patients do not achieve adequate reperfusuion and this is associated with worse patient outcomes, termed the no reflow phenomenon. This pilot study seeks to determine whether this phenomenon occurs in at risk, yet potentially salvageable brain tissue (penumbra). Funded by: NeuroSurgical Research Foundation - Grant-Research; University of Adelaide; University of Newcastle; University of Nottingham; University of Tasmania ($11,702).
  • GRANT
    WHAT CAUSES MULTIPLE SCLEROSIS ONSET AND PROGRESSION?
    1 Jan 2024 - 31 Dec 2028
    People funded by this grant:
    • Young K,
    • Fletcher J,
    • Blackburn N
    Project Total: $3,653,279; In multiple sclerosis (MS) immune cells attack the brain. A person's genes, environment and lifestyle choices can influence whether they develop MS and the severity of disease. But we don't know how these factors alter brain cell function to start or worsen MS. To figure this out, we studied families with multiple members who have MS. We identified gene mutations carried by people with MS, with the potential to change brain cells function. We will now determine how brain cells are affected. Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Grant-Ideas ($7,306,558); University of Tasmania ($480,068).
  • GRANT
    Targeting no-reflow to augment tissue salvage in stroke
    1 Apr 2023 - 31 Mar 2026
    People funded by this grant:
    • Ng F,
    • Sutherland B,
    • Campbell B,
    • Medcalf R,
    • Desmond P
    Project Total: $999,978; Ischemic stroke is due to a blocked major brain artery. Half of patients who receive acute treatment do not improve for unclear reasons. We will study one potential reason, the 'no-reflow phenomenon', where micro-blockages in small vessels stop blood reaching the brain despite unblocking the major artery. We will test how to reduce no-reflow in mice, and how it affects humans. Our ultimate aim is to develop a clinical trial for no-reflow to help brain tissue receive blood more efficiently. Funded by: Medical Research Future Fund - Grant - Cardiovascular Health Mission; University of Melbourne; University of Adelaide; Monash University; University of Tasmania.
  • GRANT
    Understanding the role of insulin in the healthy and type 2 diabetic brain
    1 Jan 2023 - 30 Sep 2024
    People funded by this grant:
    • Premilovac D,
    • Sutherland B,
    • Cullen C,
    • Foster C
    Project Total: $69,955; The aim of this project is to determine whether insulin has vascular and metabolic effects in specific regions of the brain and whether these effects are lost with insulin resistance and type 2 diabetes. This is pre-clinical work that will be performed in experimental rodents but the outcomes of the work will have wide relevance. Funded by: Diabetes Australia Research Program - Grant ($69,955); University of Tasmania.
  • GRANT
    Acquisition of a VS200 Research Slide Scanner for the College of Health and Medicine
    1 Jun 2022 - 31 May 2023
    People funded by this grant:
    • Sutherland B,
    • Howells D,
    • Courtney J-M,
    • King A,
    • Dickson T
    Project Total: $100,000; The Olympus VS200 Research Slide Scanner enables the imaging of entire tissue sections in an automated manner. It can acquire images from up to six fluorescent channels along with brightfield, dark field and phase contrast, and has objectives up to 100X. The robotic slide loader allows for batch scanning of up to 210 slides at a time and can accommodate multiple sizes of slides up to 4?x5? plates for large tissue sections. Our current VS120 slide scanner is already used at a maximum capacity with researchers having to book weeks in advance to scan slides. The VS200 will add further capacity and offers improved capabilities with greater optical resolution, more fluorescent channels, more batch scanning capacity and the ability to scan larger slides. Pairing this with free open source software like QuPath provides high throughput, efficient and highly accurate quantitative workflows that greatly improve productivity. Funded by: Ian Potter Foundation - Grant - Medical Research ($100,000); University of Tasmania.
  • GRANT
    Can metformin and exenatide improve brain vascular function in type 2 diabetes to reduce stroke severity?
    1 Jan 2022 - 31 Dec 2022
    People funded by this grant:
    • Premilovac D,
    • Sutherland B,
    • Howells D,
    • Morris G
    Project Total: $68,581; People with type 2 diabetes are four times more likely to have a stroke. As well as this, data shows that diabetic individuals who have a stroke are more likely to have a more severe stroke and are far more likely to die following a stroke. The primary treatment for stroke is to remove the clot that caused the stroke in the first place so that blood flow is restored to the affected area. Commonly prescribed anti-diabetic drugs appear to reduce diabetic stroke severity and improve patient outcomes following a stroke independently of lowering blood glucose levels, but we don't know how or why this is the case. The current project will determine whether common anti-diabetic drugs, metformin and/or glucagon like peptide 1 (GLP-1) receptor agonists such as exenatide, improve the health and function of blood vessels in the diabetic brain to reduce the impact of stroke. If true, this work will demonstrate that metformin and exenatide treatment may not only be useful for lowering blood glucose levels, but also aid in reducing the burden of stroke in those with type 2 diabetes. Funded by: Diabetes Australia Research Program - Grant ($68,581); University of Tasmania.
  • GRANT
    Detecting microvascular injury after stroke using a blood test
    1 Jan 2022 - 31 Jan 2024
    People funded by this grant:
    • Morris G,
    • Sutherland B,
    • Howells D,
    • King A,
    • Castley H
    Project Total: $9,820; Pericytes, cells controlling blood flow in the brain, are injured post-stroke. This may increase brain injury and worsen neurological disability. This project will develop a blood test for detecting pericyte injury. This test may be useful for diagnosing blood flow impairments or predicting brain injury and neurological disability post-stroke. Funded by: Royal Hobart Hospital Research Foundation - Grant-Incubator ($9,820); University of Tasmania.
  • GRANT
    Dissecting the effects of CLN3 variants on the blood-brain barrier
    1 Jan 2022 - 30 Dec 2023
    People funded by this grant:
    • Cook T,
    • Sutherland B
    Project Total: $55,000; We will use our induced pluripotent stem cell (iPSC) resource to break Batten disease down into discrete cellular contexts of the BBB - endothelial cells, pericytes, and astrocytes - to provide the advances in knowledge that can guide mechanism-based hypotheses regarding new treatment strategies. Funded by: Batten Disease Support and Research Association Australia - Grant ($55,000); University of Tasmania.
  • GRANT
    Special delivery to the brain: Using cutting-edge ultrasound to increase drug delivery to reduce brain damage after a stroke
    1 Jan 2022 - 31 Dec 2022
    People funded by this grant:
    • Premilovac D,
    • Sutherland B,
    • Howells D,
    • Castley H,
    • Guven N
    Project Total: $9,584; This project will investigate whether ultrasound can be used to deliver a drug, idebenone, specifically to the brain to reduce brain damage after a stroke in experimental rodents. Funded by: Royal Hobart Hospital Research Foundation - Grant-Incubator ($9,584); University of Tasmania.
  • GRANT
    Posthuman Genetic Legacies
    21 Jun 2021 - 6 Jun 2022
    People funded by this grant:
    • Kratz S,
    • Sutherland B,
    • Hutmacher D,
    • Nielsen J
    Project Total: $21,100; Posthuman Genetic Legacies is a practice-led research project that investigates avenues of producing an alternative (non-human) and ongoing genetic legacy via biotechnological intervention. The study draws on established practices in biological art to consider the feminist potential of cell culture and genetic engineering technologies to acquire biological offspring when conventional reproductive pathways are compromised or traditional conceptions of motherhood are undesirable. The project also aims to test the proposition that posthuman and new materialist philosophies, that disrupt binary categorisation and a human centred perspective, may offer a conceptual space for rethinking the anguish of situational childlessness. Through a range of boundary-challenging artistic examinations, existing regulatory and ethical issues will be examined to highlight the legal frameworks that govern access to reproductive technologies as well as ownership, use and patenting of biological material. Funded by: Australian Network for Art and Technology - Synapse ($21,100); University of Tasmania.
  • GRANT
    The role of the placenta in determining the post-natal effects of in utero exposure to bushfire smoke
    1 Apr 2021 - 31 Mar 2022
    People funded by this grant:
    • Zosky G,
    • Johnston F,
    • Sutherland B
    Project Total: $20,000; There is a growing body of evidence that in utero exposure to pollution events, such as bushfires, can have consequences for somatic, lung and immune development leading to an increased risk of lung disease later in life. However, there is a critical gap in the field that needs to be addressed - what is the mechanism linking in utero exposure to altered post-natal respiratory health? In novel preliminary experiments, we have data to suggest that altered placental function is the key. We hypothesise that impaired lung and immune development as a result of in utero exposure to landscape fire-derived particulate matter (PM) is due to alterations in placental structure and function. We aim to characterise the placental response to maternal exposure to bushfire smoke using samples from human placentas collected before, during and after the severe Tasmanian bushfires that occurred in the summer of 2018/19. Funded by: Australian Respiratory Council - Grant-Research ($20,000); University of Tasmania.
  • GRANT
    A new theory of fatigue: The role of AgRP neurons in ME/CFS
    1 Jan 2021 - 31 Dec 2024
    People funded by this grant:
    • Sutherland B,
    • Herzog H,
    • Landowski L
    Project Total: $268,200; Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a complex multi-system disease for which there is no cure. It is often characterised by fatigue, post-exertional malaise, cognitive dysfunction, muscle weakness, slowed reflexes and coordination, sleep disturbances, fever, myalgia, photosensitivity and neuro-immuno-endocrine dysfunction1 which can be disabling and dramatically impact quality of life. Some 190-240,000 Australians have been diagnosed with ME/CFS with many more probably undiagnosed. The fatigue experienced by patients with ME/CFS shares many features with the fatigue experienced in other conditions ranging from severe infections through cancer and brain injury to autoimmune diseases. Often the fatigue is overlooked by the medical profession and researchers alike. Never-the-less it is estimated that 38% of adults are affected by fatigue at some stage. Importantly for many, like patients with ME/CFS, there is no identifiable underlying pathology to blame and when there is a known pathology, the fatigue does not usually resolve with treatment of that pathology. We believe that fatigue is caused by an independent pathological process that can be triggered by many disease stimuli and can perpetuate independently of an associated trigger. We propose an overarching mechanism for all-cause fatigue driven by protective energy homeostasis mechanisms driven by neurons in the arcuate nucleus of the hypothalamus. These Agouti-related protein (AgRP) expressing neurons, occupy an unusual niche in the brain. They are well known for their role in regulating energy balance, but they also interact with the stress, anxiety, circadian and inflammation regulatory pathways of the hypothalamic-pituitary axis which are already known for participation in the pathology of fatigue. Importantly they are not protected by a structure called the blood-brain-barrier so are readily damaged by circulating inflammatory and stress stimuli. Moreover, they can be killed by such stimuli but also have the capacity to be replenished over time. These features make them good candidates to underpin the pathology of fatigue. We hypothesise that ME/CFS manifests when AgRP neuron signalling is impaired, resulting in a loss of homeostatic drive to promote arousal, attention and activity. We further hypothesise that restoration or replacement of AgRP neuron signalling will treat ME/CFS. We will test these hypotheses using transgenic mice developed by our multidisciplinary team that allow us to genetically control the activity of AgRP neurons and the regulation of the blood-brain-barrier and determine how they respond to inflammatory stimuli commonly used to generate animal models of ME/CFS-related fatigue. By examining how these animals then respond to drugs that change either the activity or the number of AgRP neurons, we will be able to determine whether this mechanism can be targeted to treat fatigue. If successful, these later proof-of-principle interventions may provide translatable therapies in their own right but are expected to pave the way for more refined medicinal chemistry. While the primary target of this research is finding a therapy that benefits patients with ME/CFS, our hypothesis is applicable to all forms of fatigue, whether associated with cancer, brain injury, autoimmune disease or severe infection. Importantly, while repopulation of lost AgRP neurons will take time, pharmacological mimicking of their function should produce immedi Funded by: Equity Trustees Limited - Grant-Mason Foundation ME/CFS ($268,200); University of Tasmania.
  • GRANT
    Harnessing the dual roles of pericytes to improve stroke outcomes
    1 Jan 2021 - 31 Dec 2025
    People funded by this grant:
    • Sutherland B,
    • Howells D,
    • Clarkson A,
    • Premilovac D
    Project Total: $862,943; Pericytes are cells that exclusively reside on capillaries and can actively contract or relax to modulate capillary blood flow. Pericytes also have angiogenic, stem cell and phagocytic properties that are important for brain function. In ischaemic stroke, when brain blood flow is depleted, pericytes contract and then die, leading to capillary constriction even after arterial blood flow has been restored. However, after the acute stroke period, pericytes may have an important role in brain repair. Therefore, limiting pericyte contraction acutely while promoting pericyte activity during recovery may be a novel therapeutic strategy for ischaemic stroke. Aim 1 will determine whether acute pericyte constriction of capillaries is implicated in worsening stroke outcome. We will utilise our available NG2-DsRed and PDGFR-Cre transgenic mouse lines to selectively kill (ablate) pericytes during acute period post-stroke while using our novel contrast-enhanced ultrasound paradigm to assess blood flow and stroke outcomes. In addition, we will use primary cell culture methods to analyse the secretome of neurons, astrocytes, microglia and endothelial cells following ischaemia and their effects on pericyte function. Aim 2 will investigate whether pericytes drive the recovery process of the brain following stroke. Through our aforementioned transgenic mouse lines, we will selectively ablate pericytes in the recovery phase to determine its influence on stroke outcome. We will use lineage tracing to track pericytes following stroke to determine whether pericytes migrate away from capillaries and differentiate into other cell types. Lastly, we will implant pericytes into the mouse brain post-stroke to promote recovery of the brain. This research will develop pericytes as a therapeutic target for both the acute and recovery phases of stroke, pioneering future ischaemic stroke treatment and providing novel approaches for other vascular diseases and brain injuries. Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Grant-Ideas ($1,725,886); University of Tasmania.
  • GRANT
    Is the neurovascular niche the initiation point for multiple sclerosis?
    1 Jan 2021 - 31 Dec 2023
    People funded by this grant:
    • Sutherland B,
    • Young K
    Project Total: $240,000; At present little is known about the cause of MS. This project aims to identify cellular changes that could explain some of the known risk factors and their contribution to MS pathology, and has the potential to identify cellular targets that could be used to develop tools for the early diagnosis and even prevention of MS. The specific cellular changes we are focusing on are pericytes (vascular cells only on capillaries) and oligodendrocyte precursor cells (cells that give rise to oligodendrocytes which myelinate axons in the brain). Funded by: Multiple Sclerosis Australia - Grant-Project ($240,000); University of Tasmania.
  • GRANT
    Toward targeted drug delivery to the brain using ultrasound
    1 Jan 2020 - 31 Dec 2020
    People funded by this grant:
    • Premilovac D,
    • Sutherland B,
    • Howells D,
    • Castley H
    Project Total: $9,543; All drugs given to patients in the setting of stroke are confounded by off-target effects those drugs have on other organs in the body. This pilot project will take advantage of our newly established transcranial ultrasound methods to establish a new way to deliver drugs specifically to the brain regions affected by stroke. Funded by: Royal Hobart Hospital Research Foundation - Grant-Incubator ($9,543); University of Tasmania.
  • GRANT
    Differentiation of inducible pluripotent stem cells (iPSC) into pericytes to investigate neuron-pericyte interactions
    1 May 2019 - 31 Dec 2019
    People funded by this grant:
    • Cook T,
    • Sutherland B
    Project Total: $9,980; iPSCs can be differentiated into multiple cell types, including neurons and pericytes. We wish to differentiate iPSCs from the same parental lineage into pericytes, a vascular cell with roles in blood-brain barrier maintenance and regulation of cerebral blood flow. The interaction between pericytes and neurons has not been extensively studied, and these models will allow the determination of how these cells interact leading to novel research with relevance to understanding normal brain function and how this contributes to neurodegenerative diseases. Funded by: University of Tasmania - Grant-Research Enhancement Program; University of Tasmania ($9,980).
  • GRANT
    The role of skeletal muscle pericytes in the development of insulin resistance: friend of foe?
    1 May 2019 - 31 Dec 2019
    People funded by this grant:
    • Premilovac D,
    • Sutherland B
    Project Total: $16,457; An important action of insulin in the body is to increase blood flow through capillaries in skeletal muscles. This vascular action of insulin occurs rapidly after insulin levels in the blood rise, for example following a meal, to ensure that both insulin and glucose are delivered to muscle cells to enable glucose removal from the blood. Importantly, the vascular action of insulin is lost early in development of insulin resistance and contributes to the progression of the disease. Where and how insulin acts in the vascular tree to increase muscle blood flow remains poorly understood, with insulin's potential direct effects on capillaries completely overlooked. The proposed NHMRC Ideas grant will seek to fill this gap in knowledge by demonstrating that insulin acts directly on pericytes, a contractile cell type that wrap around capillaries, to increase capillary blood flow and that these effects are lost during insulin resistance and type 2 diabetes. Funded by: University of Tasmania - Grant-Research Enhancement Program; University of Tasmania ($16,457).
  • GRANT
    An energy crisis for Alzheimer's disease: is pericyte degeneration to blame?
    1 Jan 2019 - 31 Dec 2022
    People funded by this grant:
    • Sutherland B,
    • De Luca G
    Project Total: $857,283; One possible cause of Alzheimer's disease (AD) is narrowing of small blood vessels (capillaries) within the brain, limiting blood flow and energy supply. Pericytes, a cell found only on capillaries, maintain blood flow throughout the brain. In AD, pericytes may die leading to an energy deficit and memory problems. We will test using human brains and animal models whether pericyte loss causes AD and how this is happening. Pericytes could provide a new therapy option for AD. Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Grant-Project ($1,714,566); University of Tasmania.